コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ith good leaving groups (e.g. vinyl chloride epoxide).
2 e preferentially opens cyclic anhydride over epoxide.
3 a simple oxyanion that is generated from an epoxide.
4 of an inverse rate order with respect to the epoxide.
5 family enzymes, which can metabolize PUFA to epoxides.
6 lysis in cycloaddition reactions of CO2 with epoxides.
7 r efficiently catalyzing the methanolysis of epoxides.
8 ite IRA 400 HO(-) to yield the series 1 diol epoxides.
9 r ring-opening copolymerization (ROCOP) with epoxides.
10 ion studies and the application of exogenous epoxides.
11 ines from anilines and aromatic or aliphatic epoxides.
12 r 5-exo cyclizations of suitably unsaturated epoxides.
13 putative OBPs, that is, carbamazepine 10,11-epoxide, 10,11-Dihydrocarbamazepine, 1-(2-benzaldehyde)-
15 We show that one of these analogues, CDDO-epoxide (13), is comparable to 4 in terms of cytotoxicit
16 lammation studies revealed that the terminal epoxides 17,18-EEQ-EA and 19,20-EDP-EA dose-dependently
19 eriments and on an experiment with CBZ-10,11-epoxide a transformation pathway of CBZ in intact tomato
20 efins containing an alcohol, an aldehyde, an epoxide, a carboxylic acid, or an alkenyl group may be u
21 dependence of the polymerization rate on the epoxide, a zero-order dependence on the cyclic anhydride
24 presence of esters, nitriles, alkyl halides, epoxides, acetals, alkenes, aryl halides, and silyl ethe
26 eroxides, hydroxy-dienes and other alcohols, epoxides, aldehydes and keto-dienes, was followed by (1)
27 ere, we synthesized manno-epi-cyclophellitol epoxide and aziridines and demonstrate their covalent mo
30 argeting the enzymes involved in cholesterol epoxide and glucocorticoid metabolism or GR may be novel
32 ted ixabepilone analogues in which the 12,13-epoxide and macrolactam NH moieties were replaced, the f
33 eds in a kinetic resolution, furnishing both epoxide and thiirane in high yields and enantiomeric pur
35 ains having also hydroperoxy/hydroxy groups, epoxides and aldehydes); the formation of hydroxides was
37 conditions, it was also possible to convert epoxides and an oxetane to the dichlorinated products.
40 ity for the ring-opening copolymerization of epoxides and cyclic anhydrides at low concentrations (>=
41 through the alternating copolymerization of epoxides and cyclic anhydrides compose a growing class o
42 enabled the ring-opening copolymerization of epoxides and cyclic anhydrides to afford structurally an
46 ent photoredox catalyst for the reduction of epoxides and for 5-exo cyclizations of suitably unsatura
47 e selective hydroboration of a wide range of epoxides and oxetanes yielding secondary and tertiary al
48 ctivity (up to s = 93), giving the unreacted epoxides and the corresponding protected 1,2-diols in hi
49 tes (diaminothiazine [DIAT], N-acetyl DIAT & epoxide) and cloning was attempted in a number of patien
50 ion is converted into either a trans- or cis-epoxide, and these are subsequently converted to (+)-ant
52 o many other lactones, lactides, anhydrides, epoxides, and heterocumulenes and sets the scene for a h
53 ne was the Lewis acid chosen to activate the epoxides, and onium halides or onium alkoxides involving
55 an alkB biocathode which produces alcohols, epoxides, and sulfoxides through bioelectrochemical hydr
56 pective on the current state of the field of epoxide/anhydride copolymerization mediated by discrete
58 and ring-opening copolymerization (ROCOP) of epoxides, anhydrides, and CO2 is investigated, using bot
60 ncluding olefins, alkynes, heterocycles, and epoxides are competent traps in the bromonium-induced cy
63 r inherent ring strain and electrophilicity, epoxides are highly attractive building blocks for funda
68 cs, we identify omega-3 (omega-3) fatty acid epoxides as new mast cell-derived lipid mediators and sh
70 e-pot, sequential protocol was developed for epoxide azidolysis and copper-catalyzed azide-alkyne cyc
71 an approach based on rarely studied terminal epoxide-based cation-pai bicyclizations that is describe
72 icomponent photoresins include acrylate- and epoxide-based monomers with corresponding radical and ca
73 als that the alcohol chain ends compete with epoxide binding to the Lewis acid and hydrogen-bond with
75 tabolite benzo[a]pyrene-7,8-dihydrodiol-9,10-epoxide (BPDE), using methodology applicable to correlat
76 tabolically activated to benzo[a]pyrene diol epoxide (BPDE), which then can react with DNA to form ca
77 ic monomers such as lactones, carbonates, or epoxides but also to trigger the step-growth synthesis o
80 Using an approach based on the activation of epoxides by Lewis acids and of CO2 by appropriate cation
81 polymerization of carbonyl sulfide (COS) and epoxides by metal-free Lewis pair catalysts composed of
82 an example, it is applied to the opening of epoxides by titanocene in THF, a catalytic system with a
83 his isomerization is a dihydroxy hydroperoxy epoxide (C5H10O5), which is expected to have a saturatio
85 Various alkyl-substituted cis- and trans-epoxides can be reduced to trans- and cis-alkenes, respe
90 ation of the GCase inhibitor conduritol beta-epoxide (CBE), as well as the nonlysosomal beta-glucosid
92 copolymerization of EO or PO with functional epoxide comonomers are presented as well as complex bran
95 hesis and anticancer evaluation of all known epoxide-containing communesin alkaloids and related deri
96 approach enabled the rapid synthesis of all epoxide-containing members of the communesin family from
97 iated roles for the metals in the mechanism: epoxide coordination occurs at Mg(II), with reduced tran
100 iolaxanthin cycle (VAZ cycle) and the lutein epoxide cycle (LxL cycle) are two xanthophyll cycles fou
102 butane pyrimidine dimers (CPDs) and BaP diol epoxide-deoxyguanosine (BPDE-dG), which are removed from
104 Epoxyoctadecamonoenoic acids (EpOMEs) are epoxide derivatives of linoleic acid (9,12-octadecadieno
106 identified 3 new pathways producing allylic epoxide-derived mediators that stimulate regeneration [i
108 which GCase was inhibited by conduritol beta-epoxide did not increase the amount of insoluble monomer
109 he detection of benzo[a]pyrene-7,8-diol 9,10-epoxide-DNA adduct (BPDE-DNA), which is a metabolite of
110 ioselective transformations of disubstituted epoxides, emphasizing those that have inspired the produ
112 d Meinwald rearrangement of tetrasubstituted epoxides for the synthesis of enantioenriched 2-alkynyl-
114 Retention of C1 configuration and trans-epoxide formation become predominant with the bulk-reduc
115 es ~95% selectivity for C1 inversion and cis-epoxide formation via steric guidance of a radical-coupl
116 this includes diastereo- and regioselective epoxide formation/trichloroacetic acid cleavage to gener
117 bon center in citridone B is catalyzed by an epoxide-forming P450 enzyme, followed by carbon skeletal
118 olation of various thymine and thymidine 5,6-epoxides from the corresponding trans-5,6-bromohydrins b
119 hydic H-shift and ring-closure to produce an epoxide functionality could be competitive with classic
120 fatty amides, aldehydes, ketones, alcohols, epoxides, furans, pyrans and terpenic oxygenated derivat
122 ikely attributable to the corresponding PUFA epoxides generated in tumor cells and/or host, since man
123 rly stage introduction of the trisubstituted epoxide group is reported, allowing access to the natura
124 and cis-nonachlors (TN, CN), heptachlor exo-epoxide (HEPX), dieldrin (DIEL), chlorobornanes (SigmaCH
125 mediates shed some light on the mechanism of epoxide hydrogenolysis, and further, deuterium labeling
127 uctural underpinnings of the enzyme's unique epoxide hydrolase (EH) activity, involving Zn(2+), Y383,
128 of neonatal faeces indicated that bacterial epoxide hydrolase (EH) genes are more abundant in the gu
129 depended upon co-administration of a soluble epoxide hydrolase (EPHX2) inhibitor in males, and/or wer
130 (SIM) to study the kinetics of human soluble epoxide hydrolase (hsEH), an enzyme involved in cardiova
134 n of dual-target ligands that target soluble epoxide hydrolase (sEH) and the peroxisome proliferator-
138 l trials combined with inhibition of soluble epoxide hydrolase (sEH) as anti-inflammatory strategy pr
139 enetic ablation or inhibition of the soluble epoxide hydrolase (sEH) enzyme led to increased levels o
140 HA metabolism by cytochrome P450 and soluble epoxide hydrolase (sEH) enzymes affects retinal angiogen
141 revious study showed that inhibiting soluble epoxide hydrolase (sEH) increased EET concentration and
143 The emerging pharmacological target soluble epoxide hydrolase (sEH) is a bifunctional enzyme exhibit
145 of the cyclooxygenase-2 (COX-2) and soluble epoxide hydrolase (sEH) pathways prevented the debris-in
146 erging of 5-lipoxygenase (5-LOX) and soluble epoxide hydrolase (sEH) pharmacophores led to the discov
147 n vivo pharmacological inhibition of soluble epoxide hydrolase (sEH) reduces inflammatory diseases, i
148 r studies identified oxamide 2b as a soluble epoxide hydrolase (sEH) stable replacement but unsuitabl
149 ompounds, which are converted by the soluble epoxide hydrolase (sEH) to dihydroxylethersatrienoic aci
150 ne, and because its protein product, soluble epoxide hydrolase (sEH), converts bioactive epoxides of
151 -regulates cyclooxygenase-2 (COX-2), soluble epoxide hydrolase (sEH), ER stress-response genes includ
155 e hydrolase activity of M. thermoresistibile epoxide hydrolase A (Mth-EphA) and report its crystal st
158 oli expressing recombinant Aspergillus niger epoxide hydrolase as the model enzyme for various enanti
159 nd immunological evidence that the bacterial epoxide hydrolase Cif disrupts resolution pathways durin
160 he hypotheses that inhibition of the soluble epoxide hydrolase enzyme can result in an increase in th
163 cificity that implicates participation of an epoxide hydrolase in converting epoxyalcohol to triol.
166 e report findings that inhibition of soluble epoxide hydrolase reduces inflammation, oxidative stress
167 eficial biofilm was engineered to produce an epoxide hydrolase so that it efficiently removes the env
168 Here, we show that a secreted P. aeruginosa epoxide hydrolase, cystic fibrosis transmembrane conduct
171 s M. tuberculosis has six putative genes for epoxide hydrolases (EH) of the alpha/beta-hydrolase fami
172 s the founding member of a distinct class of epoxide hydrolases (EHs) that triggers the catalysis-dep
173 squalene epoxidases, triterpenoid synthases, epoxide hydrolases, cytochrome P450s, and UDP-glucosyltr
175 ido)-dodecanoic acid (AUDA), an inhibitor of epoxide hydrolysis, inhibited VCAM-1 and ICAM-1 expressi
178 groundbreaking examples include the role of epoxides in aerosol formation especially from isoprene,
180 drogen peroxide, providing the corresponding epoxides in good to excellent yields and enantioselectiv
181 ar crossover reaction delivers corresponding epoxides in good to high enantioselectivity and constitu
183 ce using the covalent inhibitor conduritol-B-epoxide induced a profound increase in soluble alpha-syn
184 two critical construction reactions: (1) an epoxide-initiated, beta-ketoester-terminated polycycliza
186 ompounds we found that the synthetic maresin epoxide intermediate 13S,14S-eMaR (13S,14S-epoxy- 4Z,7Z,
187 nal enzyme that converts the highly unstable epoxide intermediate LTA4 into LTB4, a potent leukocyte
188 on in which isocyanides are able to open the epoxide intermediate of the Bargellini reaction affordin
189 he hydrogenolysis between two diastereomeric epoxide intermediates shed some light on the mechanism o
190 it is established that the isomerization of epoxides into allylic alcohols catalyzed by supported Au
192 The first step of the ring opening of the epoxide is the rate-determining step of these reactions.
197 duced the steady-state production of omega-3 epoxides, leading to attenuated mast cell activation and
199 are proposed to act via a 1,2-anhydrosugar "epoxide" mechanism that proceeds through an unusual conf
200 uct formed between deoxyguanosine and a diol epoxide metabolite of BaP, with subsequent mutation of c
202 various electrophiles such as alkyl halides, epoxides, Michael acceptors, and lambda(3)-iodanes in mo
205 n-dependent RslO5 reductively ring-opens the epoxide moiety of an advanced polycyclic intermediate to
208 ith a particular focus on the most important epoxide monomers ethylene oxide (EO), propylene oxide (P
209 tion of multimaterial parts containing stiff epoxide networks contrasted against soft hydrogels and o
210 IEPOX was assessed through a series of model epoxide-nucleophile experiments using nuclear magnetic r
211 shift was observed directly adjacent to the epoxide-nucleophile linkage, with smaller decreases in c
212 ly, the linoleic acid metabolite 9,10-EpOME (epoxide of linoleic acid) as well as the lysophospholipi
213 rsion of configuration at C1, yields the cis-epoxide of the drug [(1R,2S)-epoxypropylphosphonic acid
214 ed access to the oppositely configured 12,13-epoxides of 12-epoxyobtusallene II and 12-epoxyobtusalle
215 epoxide hydrolase (sEH), converts bioactive epoxides of polyunsaturated fatty acid (PUFA) to the cor
216 rategies involving BF3.Et2O-catalyzed ketone-epoxide opening and gold-catalyzed glycosylation reactio
217 The same sequence employing an epoxidation/epoxide opening in place of dihydroxylation furnishes ma
218 rayed involving a radical-mediated reductive epoxide opening reaction of N-tethered epoxy-indoles tha
219 able Mukaiyama aldol reaction, Nicolaou-type epoxide opening reaction, stereoselective Corey-Chaykovs
220 e the C7 stereocenter and a stereoconvergent epoxide opening to establish the trans-diaxial diol func
221 v alcohols by combining titanocene-catalyzed epoxide opening with chromium-catalyzed hydrogen activat
222 e key transformations used, a regioselective epoxide opening, a Pd-catalyzed addition of terminal alk
223 se I, inspired by the proposed biosynthesis, epoxide-opening cascades assemble 10 out of 15 cyclic et
224 l products involves a kinetically disfavored epoxide-opening cyclic ether formation, a reaction terme
226 inly from cyclopropanols, cyclopropenols and epoxides or aziridines are applied to the synthesis of a
227 ycosylation with Schmidt-type donors, glycal epoxides, or under dehydrative conditions with C1 alcoho
230 Taken together, the omega-3 endocannabinoid epoxides' physiological effects are mediated through bot
231 n the iron(II) oxidation state and selective epoxide polymerization was observed in the iron(III) oxi
233 ent and in some cases metal-free methods for epoxide polymerization, i.e., the activated monomer stra
234 GST)2, mGST3, and GST-mu (GSTM)4] from their epoxide precursors [16S,17S-epoxy-PD (ePD) and 13S,14S-e
235 amyotrophic lateral sclerosis, conduritol B epoxide preserved ganglioside distribution at the neurom
237 ntroduction of a vinyl or allyl group to the epoxide produced the diene derivatives that were subject
244 vIL-6 with the ER membrane protein vitamin K epoxide reductase complex subunit 1 variant 2 (VKORC1v2)
245 ncharacterized ER membrane protein vitamin K epoxide reductase complex subunit 1 variant 2 (VKORC1v2)
246 ith a nonsignaling receptor called vitamin K epoxide reductase complex subunit 1 variant 2 (VKORC1v2)
247 and the novel ER membrane protein vitamin K epoxide reductase complex subunit 1 variant-2 (VKORC1v2)
248 ly used anticoagulants that target vitamin K epoxide reductases (VKOR), a family of integral membrane
249 To understand how QueG is able to perform epoxide reduction, an unprecedented reaction for a Cbl-d
252 tic activities of LTA4H, alternating between epoxide ring opening and peptide bond hydrolysis, assist
257 ard sequential reactions with a nucleophile (epoxide ring-opening by chloride) and an electrophile (O
258 loits mechanistic switches between anhydride/epoxide ring-opening copolymerization, epoxide ring-open
259 dride/epoxide ring-opening copolymerization, epoxide ring-opening polymerization and lactone ring-ope
261 poxidation and elaborated via regioselective epoxide-ring opening and diastereoselective bromoetherif
262 onyl-phenol adducts were produced firstly by epoxide-ring opening initiated by the attack of one phen
263 n by chloride-assisted glycidol rupture (the Epoxide Route) and compared it with pH measurements by c
264 Here, we report an indole-based quinone epoxide scaffold with a unique boat-like conformation th
265 tural analysis and comparison with unreacted epoxides show that this compound indeed binds in the (4)
267 no lesion formed in the reaction of DNA with epoxides substituted with good leaving groups (e.g. viny
269 tion pathway starts with the formation of an epoxide that is opened upon the addition of a second equ
271 ugh derived specifically from the opening of epoxides, the prediction capabilities of the model, buil
272 recyclable catalyst for CO(2) fixation with epoxides; there is no significant loss of catalytic acti
273 (24) comprise two steps: ring opening of the epoxide to a carbocation intermediate followed by migrat
276 ed to the kinetic resolution of select trans-epoxides to give synthetically useful selectivity factor
277 e generated in situ and can catalyze various epoxides to give the corresponding beta-hydroxyesters in
278 within cytosol and peroxisomes that converts epoxides to the corresponding diols and hydrolyzes phosp
280 anthin (all-E)-antheraxanthin and lutein 5,6-epoxide, together with (all-E)-lutein, (all-E)-zeaxanthi
281 olling the regioselectivity of disubstituted epoxide transformations is often particularly challengin
283 ulin, dihydrobetulinic acid, and abeo-lupane epoxides under acidic conditions (HCl, montmorillonite K
285 rization of a broad array of monomers (e.g., epoxides, vinyl ethers, alkenes, cyclic ethers, and lact
290 was active for the polymerization of various epoxides, whereas the analogous neutral iron(II) complex
292 lesterol, the stereoisomeric cholesterol-5,6-epoxides, which account for 12% of the oxidation product
293 we developed a kinetic resolution of racemic epoxides, which proceeds with high selectivity (up to s
295 f the corresponding activated aziridines and epoxides with amines followed by p-toluenesulfonic acid
300 g a comprehensive review on the reactions of epoxides with titanium(III) reagents, we encountered a s